D.E. Shaw & Co
NARI

D.E. Shaw & Co’s Inari Medical, Inc. Common Stock NARI Stock Holding History

D.E. Shaw & Co’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,800
Closed -$506K – 4828
2023
Q4 		$506K Buy
+7,800
New +$470K ﹤0.01% 3504
2022
Q4 		– Sell
-30,118
Closed -$2.19M – 5200
2022
Q3 		$2.19M Buy
30,118
+16,120
+115% +$1.2M ﹤0.01% 2919
2022
Q2 		$952K Buy
+13,998
New +$1.01M ﹤0.01% 3670
2021
Q4 		– Sell
-3,470
Closed -$281K – 5779
2021
Q3 		$281K Sell
3,470
-56,288
-94% -$4.73M ﹤0.01% 4398
2021
Q2 		$5.57M Buy
59,758
+24,552
+70% +$2.38M ﹤0.01% 1946
2021
Q1 		$3.77M Sell
35,206
-3,699
-10% -$384K ﹤0.01% 2074
2020
Q4 		$3.4M Buy
+38,905
New +$2.75M ﹤0.01% 2168

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

D.E. Shaw & Co's NARI Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2024, closing a stake of 7,800 shares — an estimated $506K sold.

D.E. Shaw & Co first reported a position in NARI in Q4 2020 and held it in 7 quarters. The position peaked at $5.57M in Q2 2021. 231 funds tracked by Wall St. Rank hold NARI as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 7,800 Inari Medical, Inc. Common Stock shares in Q1 2024, an estimated $506K.
  • D.E. Shaw & Co first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • D.E. Shaw & Co's Inari Medical, Inc. Common Stock position peaked at $5.57M in Q2 2021.
  • 231 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.